CHAPTER 430

H.P. 209 - L.D. 254

An Act To Require Full Disclosure of Prescription Drug

Marketing Costs

Be it enacted by the People of the State of Maine as follows:

Sec. 1. 22 MRSA §2699 is enacted to read:

§2699.__Marketing costs

A manufacturer or labeler of prescription drugs dispensed in this State that employs, directs or utilizes marketing representatives in this State shall report marketing costs for prescription drugs in this State as provided in this section.

1.__Purposes.__Marketing costs for prescription drugs in this State must be reported to the department for the purposes of assisting this State in its role as a purchaser of prescription drugs and an administrator of prescription drug programs, enabling this State to determine the scope of prescription drug marketing costs and their effect on the cost, utilization and delivery of health care services and furthering the role of this State as guardian of the public interest.

2.__Definitions.__As used in this section, unless the context otherwise indicates, the following terms have the following meanings.